Kamalnayan Gupta

Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer

Gianmarco Leone, Francesco Orlando, Peter Dutey‐Magni, Osvaldas Vainauskas et autres

This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within the gene body and/or enhancer region.

gb, it (code pays fourni par la source)

Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

Chris Parker, Noel W. Clarke, Adrian Cook, Howard Kynaston et autres

BACKGROUND: Previous evidence indicates that adjuvant, short-course androgen deprivation therapy (ADT) improves metastasis-free survival when given with primary radiotherapy for intermediate-risk and high-risk localised prostate cancer. However, the value of ADT with postoperative radiotherapy after radical prostatectomy is unclear. METHODS: RADICALS-HD was …

gb, ca, dk (code pays fourni par la source)

Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial

Nalinie Joharatnam‐Hogan, Fay Cafferty, Richard Hubner, Daniel Swinson et autres

gb, in (code pays fourni par la source)

Breast Oncology: A Perspective

Kamalnayan Gupta

EP-1099: Favourable outcomes with systemic anti cancer chemotherapy in Head and Neck cancer at a UK tertiary cancer centre

Kamalnayan Gupta, K. Mais, L.W. Lee, Adrian Jonathan Sykes et autres

Chapter-006 Shock in Childrenurgeonӳ Perspective

Kamalnayan Gupta